Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis

John P Lydon1, Bert W O'Malley

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.

Endocrinology
|November 5, 2010
PubMed

Insights

Steroid receptor coactivator-3 (SRC-3) drives breast cancer invasion and metastasis. This oncogenic coregulator promotes cell motility and extracellular matrix degradation, highlighting its role as a prometastatic factor.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Steroid receptor coactivator-3 (SRC-3) is a member of the SRC/p160 family, acting as a crucial coregulator in various signaling pathways.
  • While SRC-3's role in mammary gland tumor proliferation is known, its function in tumor cell motility and invasion is a recent discovery.
  • SRC-3's pleiotropic nature allows it to influence numerous signaling networks vital for both normal physiology and disease states.

Purpose of the Study:

  • To elucidate the role of SRC-3 in tumor cell motility and invasion within the context of breast cancer.
  • To investigate the mechanisms by which SRC-3 contributes to the early stages of the invasion-metastasis cascade.
  • To explore the potential of SRC-3 as a therapeutic target for breast cancer intervention.

Main Methods:

  • Analysis of SRC-3's nuclear functions in epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) degradation.
  • Investigation of a truncated SRC-3 isoform (SRC-3Δ4) at the plasma membrane as a signaling adaptor.
  • Examination of the epidermal growth factor (EGF) signaling pathway involving focal adhesion kinase (FAK) and c-Src.

Main Results:

  • Nuclear SRC-3 is essential for executing EMT, conferring motility and invasive properties to cancer cells.
  • SRC-3 facilitates the proteolytic breakdown of the ECM by matrix-metalloproteinases, aiding tumor cell invasion.
  • A truncated SRC-3 isoform (SRC-3Δ4) acts as a signaling adaptor in the EGF-induced FAK-c-Src pathway, crucial for cell migration and invasion.

Conclusions:

  • SRC-3 functions as both a proto-oncogene and a prometastatic factor in the early invasion-metastasis cascade of breast cancer.
  • Understanding SRC-3's multifaceted roles provides critical mechanistic insights into mammary tumor progression.
  • These findings offer new avenues for developing diagnostic and therapeutic strategies for breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...